Skip to content
Mahaz News
US
World
Business
Entertainment
Technology
Sports
Health
Search for:
Home
FR:SAN
Business
Sell AstraZeneca, says UBS, which upgrades European rivals together with GSK
Business
Sanofi suffers main blow as its cutting-edge most cancers drug disappoints in Phase III trials
Business
Sanofi will get FDA approval for hemophilia drug
Business
Sanofi revenue narrowly beats forecasts, sees stronger earnings development in 2023